Safety [R]Evolution Titelbild

Safety [R]Evolution

Safety [R]Evolution

Von: Veeva Systems
Jetzt kostenlos hören, ohne Abo

Nur 0,99 € pro Monat für die ersten 3 Monate

Danach 9.95 € pro Monat. Bedingungen gelten.

Über diesen Titel

Safety [R]Evolution is a Veeva podcast that brings insights from Safety leaders with diverse backgrounds — life sciences organizations, technology and business consulting, CROs, and more. Discussing the importance of modernizing pharmacovigilance to deliver products quickly and safely to patients, each of our guests is interviewed by David Kološić, Director of Veeva Safety Strategy.

Learn how innovation, simplification, and standardization across processes and technology are driving a Safety [R]Evolution.

Copyright 2025 All rights reserved.
Wissenschaft
  • Building a Connected Safety Platform for the Future
    Dec 10 2025

    David Kološić speaks with Veeva’s Marius Mortensen about the long-term vision for Veeva Safety; the benefits of starting with a trusted, validated cloud platform; and how a platform approach enables connected data and processes, advanced automation, and AI.

    Mehr anzeigen Weniger anzeigen
    29 Min.
  • Strengthening Safety Oversight for CRO-Sponsor Partnerships
    Nov 3 2025

    Biomapas’ Martijn van de Leur and Olga Asimaki join David Kološić to discuss the importance of CRO-sponsor partnerships in pharmacovigilance. They also talk about the need for simplification and standardization, progress on automation and AI, and how QPPV’s are adapting to shifting technology.

    Mehr anzeigen Weniger anzeigen
    36 Min.
  • Three Pillars of PV Transformation: Technology, Process, and People
    Oct 2 2025

    In Episode 2, Eliquent Life Sciences’ Emma-Jane Brookes and Jamie Portnoff speak with David Kološić about simplifying and standardizing PV technology, harmonizing processes across teams and regions, and driving PV transformation through effective change management. Disclaimer: The views expressed are those of the individuals and do not represent Eliquent Life Sciences.

    Mehr anzeigen Weniger anzeigen
    34 Min.
Noch keine Rezensionen vorhanden